Covid-19 news

23 Mar 2020

Various media have reported on studies addressing COVID-19 to be undertaken by several research centres in Catalonia. Among the groups involved is IRB Barcelona’s Structural Bioinformatics and Network Biology Lab, headed by Patrick Aloy. IRB Barcelona  is one of eight research centres chosen by the European Commission to study new approaches to treat and diagnose COVID-19 and thus halt the spread of the virus.

Furthermore, NostrumBiodiscovery, cofounded by IRB Barcelona researcher Modesto Orozco, is collaborating with the Barcelona Supercomputing Center–Centro Nacional de Supercomputación (BSC-CNS) in another EC project. In this regard, the project aims to use cutting-...

23 Mar 2020

Against the backdrop of the current health crisis, IRB Barcelona has been following the directives of the authorities to guarantee the health of its employees, to contribute to preventive measures to stop the spread of COVID-19, and to minimize the impact of these measures on the lines of research undertaken at the Institute. The aim is to guarantee minimum services and the maintenance of the Institute's research facilities and tools.

The work done by our computational scientists and many of the lab and administration tasks will continue to be undertaken. However, some projects have inevitably been suspended until things get back to normal and we can return to work. IRB Barcelona...

16 Mar 2020

The programme La Sexta Columna broadcasted by La Sexta has interviewed Patrick Aloy, head of the Structural Bioinformatics and Network Biology laboratory at IRB Barcelona, about the participation of his team in a European research project devoted to COVID-19. Aloy explains that the project will study the efficacy of more than 5000 drugs to fight this coronavirus. The scientist says, "If we do not get any results from these 5000 or 7000 compounds, we will have to widen the search and examine the million compounds that are available".

Link to: La Sexta Columna (minute 41: 10-42: 50)

   
10 Mar 2020

The European Commission has awarded funding to 17 research projects in a special call announced to tackle the coronavirus. IRB Barcelona’s Structural Bioinformatics and Network Biology Lab, headed by Patrick Aloy,  is participating in one of these projects, together with other research centres. The project, called RiPCoN, will perform a computational study of the interactions between coronavirus and human cells, with the aim to identify drugs (already on the market or in trials)  that can halt the spread of the virus. 

Various media have reported on Spain’s participation  in 6 of the 17 projects chosen by the European Commission to advance and speed up research into the...